Cefuroxime And Dextrose In Duplex Container

   
Google
 
Web NewDrugInformation.com

Cefuroxime And Dextrose In Duplex Container


Drug - Cefuroxime And Dextrose In Duplex Container
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Cefuroxime Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 750MG BASE/VIAL
The potency of the active ingredient(s), Cefuroxime Sodium. May repeat for multiple part products.

Applicant - B BRAUN
The firm name holding legal responsibility for Cefuroxime And Dextrose In Duplex Container. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 050780
The FDA assigned number to Cefuroxime And Dextrose In Duplex Container. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cefuroxime And Dextrose In Duplex Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 21, 2001
The date Cefuroxime And Dextrose In Duplex Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Cefuroxime And Dextrose In Duplex Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cefuroxime And Dextrose In Duplex Container is in. Format is RX, OTC, DISCN.

Applicant Full Name - B Braun Medical Inc
The full name of the firm holding legal responsibility for the new application of Cefuroxime And Dextrose In Duplex Container.

Cefuroxime And Dextrose In Duplex Container